Skip to content
SPC Logo

Gammanorm

Last Updated on eMC 22-Jun-2017 View document  | Octapharma Limited Contact details

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC.  For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 22-Jun-2017 and displayed until Current

Reasons for adding or updating:

  • Change to section 6.4 - Special precautions for storage
  • Change to section 10 - Date of revision of the text
  • Correction of spelling/typing errors

Date of revision of text on the SPC: 19-Jun-2017

Legal Category:POM

Black Triangle (CHM): NO

Free-text change information supplied by the pharmaceutical company:

Section 6.4: Update of RT shelf life now for up to 6 months (within overall shelf life). Previously 2 months.

Updated on 19-Mar-2015 and displayed until 22-Jun-2017

Reasons for adding or updating:

  • Correction of spelling/typing errors

Date of revision of text on the SPC: 18-Dec-2014

Legal Category:POM

Black Triangle (CHM): NO

Updated on 16-Mar-2015 and displayed until 19-Mar-2015

Reasons for adding or updating:

  • Change to section 2 - Qualitative and quantitative composition
  • Change to section 3 - Pharmaceutical form
  • Change to section 4.8 - Undesirable effects
  • Change to section 6.5 - Nature and contents of container
  • Change to section 10 - Date of revision of the text

Date of revision of text on the SPC: 31-Dec-2014

Legal Category:POM

Black Triangle (CHM): NO

Free-text change information supplied by the pharmaceutical company:

$0Section 2: New vial Sizes Added$0$0Section 3: Rewording of pharmaceuticalform.$0$0Section 4.8: New MHRA ADR reportingstatement Added$0$0Section 4.8: TEE’s added to side effectstable$0$0Section 6.5: New vial sizes added$0

Updated on 05-Nov-2013 and displayed until 16-Mar-2015

Reasons for adding or updating:

  • Removal of black triangle

Date of revision of text on the SPC: 24-Feb-2012

Legal Category:POM

Black Triangle (CHM): NO

Free-text change information supplied by the pharmaceutical company:

Black Triangle Status Removed.  No further changes

Updated on 16-Mar-2012 and displayed until 05-Nov-2013

Reasons for adding or updating:

  • Change to section 3 - Pharmaceutical form
  • Change to section 6.1 - List of Excipients

Date of revision of text on the SPC: 24-Feb-2012

Legal Category:POM

Black Triangle (CHM): YES

Free-text change information supplied by the pharmaceutical company:



·         CC2010-266: Addition of Polysorbate 80 to Gammanorm after UF

·         CC2011-184: Lower limit of Polysorbate 80 in FPS: 20 µg/ml

 


·         Corrections in section 3 “Purification process columns”

Updated on 10-Aug-2010 and displayed until 16-Mar-2012

Reasons for adding or updating:

  • New SPC for new product

Legal Category:POM

Black Triangle (CHM): YES

Company contact details

Octapharma Limited

Company image
Address

The Zenith Building, 26 Spring Gardens, Manchester, Lancashire, M2 1AB

Fax

+44 (0)161 837 3799

Medical Information e-mail
Telephone

+44 (0)161 837 3770

Medical Information Direct Line

0845 1300 522

Medical Information Fax

+44 (0)161 837 3799

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Active ingredients

human normal immunoglobulin

Legal categories

POM - Prescription Only Medicine

This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Continue